Premium
Circadin: a new option in sleep disorders
Author(s) -
Greener Mark
Publication year - 2008
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.95
Subject(s) - insomnia , melatonin , sleep (system call) , sleep quality , psychology , medicine , psychiatry , neuroscience , computer science , operating system
Circadin ‐ a prolonged‐release formulation containing 2mg melatonin ‐ offers a promising short‐term treatment for primary insomnia that is characterised by poor sleep quality in patients aged 55 years or over. Medical writer, Mark Greener, reviews this new addition to the sleep treatment armamentarium. Copyright © 2008 Wiley Interface Ltd